Gains Nasal Delivery Technologies and Expands Product Pipeline Oragenics, Inc. and Odyssey Health, Inc. announce the signing of a definitive agreement under which Oragenics will acquire Odyssey’s assets related to its proprietary neurological drug therapies and technologies.
